The risks of CHB-M, CHB-S, and ACLF cases with 7 site mutations on the basis of genotype B and genotype C as compared with ASCs, CHB-M and CHB-S respectively.
<p>ASC, asymptomatic hepatitis B surface antigen carriers; CHB-M, mild chronic hepatitis B; CHB-S, severe chronic hepatitis B; ACLF, acute on chronic liver failure; CI, confidence interval; AOR, adjusted odds ratio;</p><p>* compared with ASCs;</p><p>** compared with CHB-M;</p><p>*** compared with CHB-S.</p><p><sup>a</sup><i>P</i> < 0.01, as compared with control.</p><p><sup>b</sup><i>P</i> < 0.05, as compared with control.</p><p>The risks of CHB-M, CHB-S, and ACLF cases with 7 site mutations on the basis of genotype B and genotype C as compared with ASCs, CHB-M and CHB-S respectively.</p
